Judge Lets Gout Drug Antitrust Suit Move Forward

By Nadia Dreid · May 25, 2023, 5:18 PM EDT

An antitrust suit accusing Takeda Pharmaceuticals of striking anti-competitive deals to beat back generic competition on its anti-gout drug Colcrys is teed up for trial after a Pennsylvania federal judge refused...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

VALUE DRUG COMPANY v. TAKEDA PHARMACEUTICALS, U.S.A., INC. et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2021

Recent Articles By Nadia

November 19, 2024
DC Circ. Wonders Where To Land On Terrorism Liability Claims
November 07, 2024
Sutter Health Could Face Retrial On Antitrust Claims In March
July 17, 2024
Teladoc Hit With Another Investor Suit Over BetterHelp Woes
July 11, 2024
Pfizer's $50M EpiPen Deal Gets Final OK In Antitrust Suit
June 27, 2024
Judge OKs $10M Deal In Generic Price-Fixing MDL
April 16, 2024
NC Treasurer Backs FTC On Hospital Merger Challenge
April 09, 2024
White House, Senate Dems Want $1.3B To Fight COVID Fraud
March 01, 2024
NY Judge Tosses $6.4B BMS Investor Action For Good
February 21, 2024
39 AGs Call For Federal Pharmacy Benefit Manager Reform
February 05, 2024
States Ask Justices To End Feds' Alleged Online Censorship